ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: John Campbell, Nida Contracts Chief, New Head Of NCI Contracts Branch; PHS Honors Seven At NCI

June 10, 1983

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

Emory Cancer Experiment Launched Into Space

January 17, 2003